JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abidov, A.
Right arrow Articles by Berman, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abidov, A.
Right arrow Articles by Berman, D. S.
Journal of Nuclear Medicine Vol. 45 No. 12 1999-2007
© 2004 by Society of Nuclear Medicine


Clinical Investigations

Integration of Automatically Measured Transient Ischemic Dilation Ratio into Interpretation of Adenosine Stress Myocardial Perfusion SPECT for Detection of Severe and Extensive CAD

Aiden Abidov, MD, PhD1, Jeroen J. Bax, MD2, Sean W. Hayes, MD1, Ishac Cohen, PhD1, Hidetaka Nishina, MD1, Shunichi Yoda, MD1, Xingping Kang, MD1, Fatma Aboul-Enein, MD1, James Gerlach1, John D. Friedman, MD1, Rory Hachamovitch, MD3, Guido Germano, PhD1 and Daniel S. Berman, MD1

1 Cedars-Sinai Medical Center, Los Angeles, California
2 Leiden University Medical Center, Leiden, The Netherlands
3 Keck School of Medicine, University of Southern California, Los Angeles, California

The aim of our study was to derive and to validate the normal threshold for an automatically measured left ventricular transient ischemic dilation (TID) ratio in patients referred for adenosine stress myocardial perfusion SPECT (MPS) and to assess the value of integrating TID in detecting severe and extensive coronary artery disease (CAD). Methods: Normal limits for the TID ratio were derived using dual-isotope MPS data from 38 patients with a low (<5%) likelihood of CAD. Criteria for abnormality were calculated on the basis of data from 179 consecutive patients who had undergone coronary angiography less than 3 mo after index adenosine MPS: 41 patients (23%) had severe and extensive CAD (≥90% stenosis) in the proximal left anterior descending artery or in 2 or more coronary arteries, 64 (36%) had no significant CAD (<70% stenosis), and 74 (41%) had mild or moderate CAD. The criteria were then prospectively validated in a cohort of 177 patients, of whom 41 patients (23%) had severe and extensive CAD, 55 (31%) had no significant CAD, and 81 (46%) had mild or moderate CAD. Results: By analysis of receiver-operating-characteristic curves, the best threshold for adenosine TID ratio abnormality was the mean adenosine TID ratio in the low-CAD-likelihood patients + 2 SDs (TID ratio > 1.36). Abnormal TID ratio using this threshold demonstrated high sensitivity and specificity for severe and extensive CAD (71% and 86%, respectively), and similar sensitivity and specificity were observed in the prospective validation group (73% and 88%, respectively). In the combined pilot and validation groups, the absence of both abnormal TID ratio and abnormal perfusion was highly specific for the absence of severe and extensive CAD; only one (1.3%) of 79 patients with severe and extensive CAD had neither of these abnormal findings on adenosine MPS. In patients with both abnormal TID ratio and abnormal perfusion, 55 of 84 (65%) had severe and extensive CAD. When patients had one but not both of these findings, 26 of 193 (13%) had severe and extensive CAD. Conclusion: The automatically measured TID ratio is a useful clinical marker that is sensitive and highly specific for identification of severe and extensive CAD in patients undergoing adenosine MPS. Integration of abnormal TID ratio into the dual-isotope MPS image interpretation algorithm improves the identification of severe and extensive CAD in adenosine MPS.

Key Words: clinical cardiology • coronary artery disease • myocardial perfusion SPECT • transient ischemic dilation ratio


Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8a-9a. [Full Text]  



This article has been cited by other articles:


Home page
Circ Cardiovasc ImagingHome page
A. Abidov, R. Hachamovitch, S. W. Hayes, J. D. Friedman, I. Cohen, X. Kang, L. De Yang, L. Thomson, G. Germano, P. Slomka, et al.
Are Shades of Gray Prognostically Useful in Reporting Myocardial Perfusion Single-Photon Emission Computed Tomography?
Circ Cardiovasc Imaging, July 1, 2009; 2(4): 290 - 298.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. F. Heston and D. M. Sigg
Quantifying Transient Ischemic Dilation Using Gated SPECT
J. Nucl. Med., December 1, 2005; 46(12): 1990 - 1996.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons and P. A. Araoz
The Year in Cardiac Imaging
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 542 - 551.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.